Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-21
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed

Amends S100PKO6.

Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥417.1bn2022-04-01 → 2022-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥224.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS (5-year summary)
Revenue¥750.1bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥360.1bn2021-04-01 → 2021-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥193.3bn2021-07-01 → 2021-09-30dCons.Revenue IFRS (5-year summary)
Operating income¥93.6bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥49.1bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥70.7bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥44.7bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥89.3bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥47.3bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥141.7bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥68.4bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥43.0bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥66.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥115.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥62.4bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥43.7bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥66.9bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥62.5bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥43.8bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥1.49Tat 2022-09-30Cons.Assets IFRS
Total assets¥1.36Tat 2022-03-31Cons.Assets IFRS
Total assets¥1.19Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥842.0bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥846.6bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥644.1bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥447.2bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥395.5bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥643.0bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥510.2bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥446.1bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥255.8bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥297.4bnat 2022-09-30Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥302.6bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥193.4bnat 2021-09-30Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥6.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥169.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥68.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥15.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥71.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥50.5bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥35.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥44.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥52.52022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.972022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥90.222021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥48.532021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥342021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥52.452022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.932022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥90.172021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥48.512021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥33.982021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio43.3%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.6%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥4.3bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥68.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-09-30−¥788m
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥29.8bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥97.9bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥20.1bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2021-04-01 → 2021-09-30¥61.6bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2021-04-01 → 2021-09-30−¥1.1bn
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2021-04-01 → 2021-09-30¥30.3bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥90.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 766
ItemContextValueUnit
Notes cash and cash equivalents condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes assets held for sale condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes bonds and borrowings condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes share capital and other equity items condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes dividends condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes net sales condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes other income and other expenses condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes earnings per share condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes cash flow information condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes financial instruments condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes discontinued operations condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes business combinations condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes contingent liabilities condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes subsequent events condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass